FBTCX vs. IBIT
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class C (FBTCX) and iShares Bitcoin Trust (IBIT).
FBTCX is managed by Fidelity. It was launched on Dec 27, 2000. IBIT is a passively managed fund by iShares that tracks the performance of the CME CF Bitcoin Reference Rate - New York Variant. It was launched on Jan 5, 2024.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FBTCX or IBIT.
Correlation
The correlation between FBTCX and IBIT is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
FBTCX vs. IBIT - Performance Comparison
Key characteristics
FBTCX:
-0.37
IBIT:
2.49
FBTCX:
0.95
IBIT:
1.29
FBTCX:
7.71%
IBIT:
12.01%
FBTCX:
19.90%
IBIT:
56.83%
FBTCX:
-61.27%
IBIT:
-27.51%
FBTCX:
-33.32%
IBIT:
-9.72%
Returns By Period
In the year-to-date period, FBTCX achieves a -4.56% return, which is significantly lower than IBIT's 3.36% return.
FBTCX
-4.56%
-10.36%
-18.72%
-7.51%
-2.89%
-0.52%
IBIT
3.36%
-5.32%
47.51%
119.58%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBTCX vs. IBIT - Expense Ratio Comparison
FBTCX has a 1.75% expense ratio, which is higher than IBIT's 0.25% expense ratio.
Risk-Adjusted Performance
FBTCX vs. IBIT — Risk-Adjusted Performance Rank
FBTCX
IBIT
FBTCX vs. IBIT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and iShares Bitcoin Trust (IBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Not enough dataDividends
FBTCX vs. IBIT - Dividend Comparison
FBTCX's dividend yield for the trailing twelve months is around 3.00%, while IBIT has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBTCX Fidelity Advisor Biotechnology Fund Class C | 3.00% | 2.87% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.73% | 2.75% |
IBIT iShares Bitcoin Trust | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
FBTCX vs. IBIT - Drawdown Comparison
The maximum FBTCX drawdown since its inception was -61.27%, which is greater than IBIT's maximum drawdown of -27.51%. Use the drawdown chart below to compare losses from any high point for FBTCX and IBIT. For additional features, visit the drawdowns tool.
Volatility
FBTCX vs. IBIT - Volatility Comparison
The current volatility for Fidelity Advisor Biotechnology Fund Class C (FBTCX) is 8.23%, while iShares Bitcoin Trust (IBIT) has a volatility of 15.52%. This indicates that FBTCX experiences smaller price fluctuations and is considered to be less risky than IBIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.